• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[青蒿琥酯片不同疗程治疗恶性疟的疗效比较]

[Comparison on treatment of falciparum malaria with different courses of artesunate tablet].

作者信息

Li G Q, Fu Y X, Bian W X

机构信息

Tropical Medicine Institute, Guangzhou University of Traiditional Chinese Medicine.

出版信息

Zhongguo Zhong Xi Yi Jie He Za Zhi. 1997 Mar;17(3):143-4.

PMID:9863077
Abstract

OBJECTIVE

To assess the efficacy of Artesunate on falciparum malaria.

METHODS

A randomized controlled study on the treatment of 90 uncomplicated falciparum malaria patients was carried out with 400 mg of artesunate tablet as a total dose over 3 days, 600 mg over 5 days and 800 mg over 7 days.

RESULTS

All patients were cured. Fever clearance time (FCT) and parasite clearance time(PCT) among the three groups were similar. Parasite recrudescence rate within 28 days was 39.3% (11/ 28) in 3 day group, 6.9% (2/29) in 5 day group and 3.4% (1/29) in 7 day group (comparing 5 day group with 3 day group, P < 0.005, comparing 7 day group with 3 day group, P < 0.005).

CONCLUSION

It indicated that parasite recrudescence rate may be effectively decreased by prolonging treatment courses.

摘要

目的

评估青蒿琥酯治疗恶性疟的疗效。

方法

对90例非复杂性恶性疟患者进行随机对照研究,总剂量400毫克青蒿琥酯片分3天服用,600毫克分5天服用,800毫克分7天服用。

结果

所有患者均治愈。三组的退热时间(FCT)和寄生虫清除时间(PCT)相似。28天内的寄生虫复发率在3天组为39.3%(11/28),5天组为6.9%(2/29),7天组为3.4%(1/29)(5天组与3天组比较,P<0.005;7天组与3天组比较,P<0.005)。

结论

表明延长疗程可有效降低寄生虫复发率。

相似文献

1
[Comparison on treatment of falciparum malaria with different courses of artesunate tablet].[青蒿琥酯片不同疗程治疗恶性疟的疗效比较]
Zhongguo Zhong Xi Yi Jie He Za Zhi. 1997 Mar;17(3):143-4.
2
Comparison of oral artesunate and quinine plus tetracycline in acute uncomplicated falciparum malaria.青蒿琥酯口服制剂与奎宁加四环素治疗急性非复杂性恶性疟的比较。
Bull World Health Organ. 1994;72(2):233-8.
3
An open, randomized trial of three-day treatment with artesunate combined with a standard dose of mefloquine divided over either two or three days, for acute, uncomplicated falciparum malaria.一项开放、随机试验,比较青蒿琥酯联合标准剂量甲氟喹分两天或三天给药,进行为期三天的治疗,用于治疗急性非复杂性恶性疟。
Southeast Asian J Trop Med Public Health. 2005 May;36(3):591-6.
4
Monotherapy with sodium artesunate for uncomplicated falciparum malaria in Thailand: a comparison of 5- and 7-day regimens.青蒿琥酯单药治疗泰国非复杂性恶性疟:5天与7天疗程的比较
Acta Trop. 1997 Sep 30;67(3):197-205. doi: 10.1016/s0001-706x(97)00063-6.
5
Pharmacokinetics of mefloquine alone or in combination with artesunate.单独使用或与青蒿琥酯联合使用时甲氟喹的药代动力学。
Bull World Health Organ. 1994;72(1):83-7.
6
Dose-finding and efficacy study for i.m. artemotil (beta-arteether) and comparison with i.m. artemether in acute uncomplicated P. falciparum malaria.肌肉注射蒿甲醚(β-蒿乙醚)的剂量探索与疗效研究以及与肌肉注射蒿甲醚治疗急性非复杂性恶性疟的比较
Br J Clin Pharmacol. 2002 May;53(5):492-500. doi: 10.1046/j.1365-2125.2002.01590.x.
7
Double blind randomised clinical trial of oral artesunate at once or twice daily dose in falciparum malaria.口服青蒿琥酯每日一次或两次剂量治疗恶性疟的双盲随机临床试验。
Southeast Asian J Trop Med Public Health. 1991 Dec;22(4):539-43.
8
A randomized clinical trial of combinations of artesunate and azithromycin for treatment of uncomplicated Plasmodium falciparum malaria in Thailand.青蒿琥酯与阿奇霉素联合治疗泰国非复杂性恶性疟原虫疟疾的随机临床试验。
Southeast Asian J Trop Med Public Health. 2000 Dec;31(4):801-7.
9
Double blind randomised clinical trial of two different regimens of oral artesunate in falciparum malaria.两种不同口服青蒿琥酯方案治疗恶性疟的双盲随机临床试验。
Southeast Asian J Trop Med Public Health. 1991 Dec;22(4):534-8.
10
Dose findings of dihydroartemisinin in treatment of falciparum malaria.双氢青蒿素治疗恶性疟的剂量研究结果。
Southeast Asian J Trop Med Public Health. 1999 Mar;30(1):17-9.